Back
Sonder Holdings Vs. Blueprint Medicines Industry Stock Comparison
Sell
35
SOND
Sonder Holdings
Last Price:
$3.13
Seasonality Move:
-16.28%
Sell
43
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
35
Sonder Holdings (SOND)
is a Sell
Is Sonder Holdings a Buy, Sell or Hold?
-
The current Sonder Holdings [SOND] share price is $3.10. The Score for SOND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
SOND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SOND Stock Price Chart
What is Sonder Holdings's stock price today?
-
The Sonder Holdings share price today is $3.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOND is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $103.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 43.25 | Sell |
Chaikin Money Flow: | -9595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.15 - 3.65) | Sell |
Bollinger Bands (100): | (2.91 - 5.55) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 65.19 | Buy |
Chaikin Money Flow: | 1951173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.25 - 95.81) | Buy |
Bollinger Bands (100): | (87.04 - 95.76) | Buy |
SOND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.35 | Sell |
20-day SMA: | 3.32 | Sell |
50-day SMA: | 3.42 | Sell |
200-day SMA: | 3.93 | Sell |
8-day EMA: | 3.27 | Sell |
20-day EMA: | 3.35 | Sell |
50-day EMA: | 3.51 | Sell |
200-day EMA: | 4.48 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.01 | Buy |
20-day SMA: | 91.26 | Buy |
50-day SMA: | 93.56 | Buy |
200-day SMA: | 96.81 | Buy |
8-day EMA: | 92.7 | Buy |
20-day EMA: | 91.91 | Buy |
50-day EMA: | 92.32 | Buy |
200-day EMA: | 91.6 | Buy |
Sonder Holdings Earnings Growth & SOND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.21 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
Sonder Holdings Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |